🇺🇸 FDA

Company profile · Sponsor

Lupin

Lupin Europe GmbH

E10AC1C · EMA pharma EU
Pipeline
4
Drugs
0
Patents
0

Quick answer

Lupin (E10AC1C) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E10AC1C
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (4)

Search pipeline →

  1. Mexiletine granules for prolonged-release oral suspension 333 mg, Mexiletine granules for prolonged-release oral suspension 167 mg, Mexiletine granules for prolonged-release oral suspension 500 mg

    Lupin

    Myotonic Dystrophy type 1 and type 2 (DM1/DM2)

    phase 3 small molecule active

    1 trial

  2. Namuscla 167 mg hard capsules, Mexiletine granules for prolonged-release oral suspension 167 mg, Mexiletine granules for prolonged-release oral suspension 500 mg, Mexiletine granules for prolonged-release oral suspension 333 mg

    Lupin

    Non-Dystrophic Myotonias (NDM)

    phase 3 small molecule active

    1 trial

  3. Placebo to Mexiletine granules for prolonged-release oral suspension 167 mg, 333 mg, and 500 mg, Mexiletine granules for prolonged-release oral suspension 333 mg, Mexiletine granules for prolonged-release oral suspension 500 mg, Mexiletine granules for prolonged-release oral suspension 167 mg

    Lupin

    Myotonic Dystrophy type 1 and type 2 (DM1/DM2)

    phase 3 small molecule active

    1 trial

  4. Namuscla 167 mg hard capsules, Mexiletine 62 mg hard capsules, Mexiletine 83 mg hard capsules

    Lupin

    Myotonic disorders: Nondystrophic myotonias (NDM) or myotonic dystrophies (DM, type 1 or type 2)

    approved small molecule active

    1 trial

Frequently asked questions

What is Lupin?

Lupin (E10AC1C) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Lupin sponsor?

We track 4 ClinicalTrials.gov-linked programs for Lupin, including Mexiletine granules for prolonged-release oral suspension 333 mg, Mexiletine granules for prolonged-release oral suspension 167 mg, Mexiletine granules for prolonged-release oral suspension 500 mg and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Lupin company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.